Related Experiment Videos

Phosphorylation of S-II, a eukaryotic transcription factor, by casein kinase II

M Horikoshi, Y Nakanishi, S Hirashima

Chemical & Pharmaceutical Bulletin

|October 1, 1987

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Long-term efficacy and safety of risankizumab for the treatment of moderate-to-severe plaque psoriasis: interim analysis of the LIMMitless open-label extension trial beyond 3 years of follow-up.

The British journal of dermatology·2021

Efficacy and safety of dupilumab in Japanese adults with moderate-to-severe atopic dermatitis: a subanalysis of three clinical trials.

The British journal of dermatology·2019

Long-term efficacy and safety of tildrakizumab for moderate-to-severe psoriasis: pooled analyses of two randomized phase III clinical trials (reSURFACE 1 and reSURFACE 2) through 148 weeks.

The British journal of dermatology·2019

Analysis of treatment goal alignment between Japanese psoriasis patients and their paired treating physicians.

Journal of the European Academy of Dermatology and Venereology : JEADV·2017

Ixekizumab treatment for psoriasis: integrated efficacy analysis of three double-blinded, controlled studies (UNCOVER-1, UNCOVER-2, UNCOVER-3).

The British journal of dermatology·2017

Changes in resting-state brain networks after cognitive-behavioral therapy for chronic pain.

Psychological medicine·2017

See all related articles